BostonGene News and Activities
Presence
BostonGene provides AI-based molecular and immune profiling solutions for cancer care. Its products and services support biopharma companies, healthcare providers, and researchers with clinical decision support and drug development insights.
BostonGene products and services overview:
- Cancer diagnostics
- Molecular profiling
- Immune profiling
- Clinical analytics
- Drug development support
- Biomarker discovery
Revenue: ~$50 million
Employees: 300
Headquarters: Waltham, United States (USA)
BostonGene is one of the...
Executives
View the org chart displaying its 16 main executives
Most searched biographies at BostonGene
- Andrew Feinberg, President and Chief Executive Officer
- Michael Hensley, Senior Manager, Business Development
- Nathan Fowler, Chief Medical Officer
Create your alert
to follow the executive moves at BostonGene.
Biotechnology
BostonGene has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Popular M&A news in Biotechnology
- IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
- NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
- Rallybio and Avenzo Therapeutics have announced they will merge (posted on June 1 2026)..
Popular contacts in Biotechnology
News
Press releases by BostonGene
- BostonGene to Demonstrate Power of AI Models in Tumor and Immune Biology at the 2026 ASCO® Annual Meeting | BostonGene
- Hokkaido University Leverages BostonGene’s AI-powered Platform to Advance Precision Oncology | BostonGene
- BostonGene Receives Frost & Sullivan’s 2026 Global Company of the Year for Advancing in AI-Driven Multimodal Oncology Platforms | BostonGene
- Press releases | BostonGene
- BostonGene and ImmunoGenesis Announce Strategic Partnership to Overcome Immunotherapy Resistance | BostonGene
- BostonGene to Present 13 Abstracts at the American Association for Cancer Research Annual Meeting 2026 Showcasing AI-Platform for Drug Development | BostonGene
- BostonGene RNA Transcriptome Profiling Reveals New ADC Targets in Advanced Solid Tumors | BostonGene
- BostonGene Advances AI-Driven Disease Modeling in Oncology in Collaboration with Leading Experts in Cancer Genomics at USCAP 115th Annual Meeting | BostonGene
- BostonGene Demonstrates Disease Modeling Platform at JSMO 2026, Advancing AI-Driven Drug Development and Precision Oncology | BostonGene
- BostonGene Named ‘Innovator of the Year’ at Boston Life Sciences Times Vanguard Awards | BostonGene
- View more press releases Close
Social media about BostonGene
- BostonGene on Wikipedia, Google News & Yahoo Finance
- BostonGene on LinkedIn, X (Twitter) & YouTube
